Sandra M. Schubert-Ihne

CIRCLE Centre For Innovation Research, Box 118
Lund, M 22100, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Psycho-Emotional Profile and Disease Burden in Wild-Type Transthyretin Amyloidosis.

Psycho-Emotional Profile and Disease Burden in Wild-Type Transthyretin Amyloidosis.

Journal: Journal of clinical medicine

Published: July 16, 2026

Cardiovascular determinants of the 6-minute walk distance in cardiac transthyretin amyloidosis.

Cardiovascular determinants of the 6-minute walk distance in cardiac transthyretin amyloidosis.

Journal: BMC cardiovascular disorders

Published: June 12, 2025

Development of heart-sparing VMAT radiotherapy technique incorporating heart substructures for advanced NSCLC patients.

Development of heart-sparing VMAT radiotherapy technique incorporating heart substructures for advanced NSCLC patients.

Journal: Radiation oncology (London, England)

Published: October 25, 2024

Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis.

Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: June 05, 2024

Cardio-Hepatic Interaction in Cardiac Amyloidosis.

Cardio-Hepatic Interaction in Cardiac Amyloidosis.

Journal: Journal of clinical medicine

Published: December 27, 2023

Liver stiffness as a prognostic parameter and tool for risk stratification in advanced cardiac transthyretin amyloidosis.

Liver stiffness as a prognostic parameter and tool for risk stratification in advanced cardiac transthyretin amyloidosis.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: December 05, 2023

Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis-A Clinical Feasibility Study.

Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis-A Clinical Feasibility Study.

Journal: Journal of clinical medicine

Published: November 08, 2023

Vector autoregression: Useful in rare diseases?-Predicting organ response patterns in a rare case of secondary AA amyloidosis.

Vector autoregression: Useful in rare diseases?-Predicting organ response patterns in a rare case of secondary AA amyloidosis.

Journal: PloS one

Published: May 16, 2023

Single German centre experience with patient journey and care-relevant needs in amyloidosis: The German AMY-NEEDS research and care program.

Single German centre experience with patient journey and care-relevant needs in amyloidosis: The German AMY-NEEDS research and care program.

Journal: PloS one

Published: April 07, 2023

Tafamidis for cardiac transthyretin amyloidosis: application in a real-world setting in Germany.

Tafamidis for cardiac transthyretin amyloidosis: application in a real-world setting in Germany.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: November 08, 2022

Needs of amyloidosis patients and their care providers: design & first results of the AMY-NEEDS research and care program.

Needs of amyloidosis patients and their care providers: design & first results of the AMY-NEEDS research and care program.

Journal: Orphanet journal of rare diseases

Published: June 24, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026